COST-EFFECTIVENESS OF PHARMACEUTICALS .5. COST-BENEFIT AND COST-EFFECTIVENESS ANALYSIS OF DRUG-THERAPY

被引：20

作者：

DAO, TD

机构：

来源：

AMERICAN JOURNAL OF HOSPITAL PHARMACY | 1985年 / 42卷 / 04期

关键词：

D O I：

10.1093/ajhp/42.4.791

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：791 / 802

页数：12

共 40 条

[1]

[Anonymous], 1979, JAMA, V242, P2562

[2]

[Anonymous], 1982, JAMA, V247, P633

[3]

[Anonymous], 1979, JAMA, V242, P2572

[4]

[Anonymous], 1982, JAMA, V248, P1465

[5]

BAUMOL WJ, 1968, AM ECON REV, V58, P788

[6] THE SICKNESS IMPACT PROFILE - DEVELOPMENT AND FINAL REVISION OF A HEALTH-STATUS MEASURE [J].

BERGNER, M ;

BOBBITT, RA ;

CARTER, WB ;

GILSON, BS .

MEDICAL CARE, 1981, 19 (08) :787-805

[7] SICKNESS IMPACT PROFILE - CONCEPTUAL FORMULATION AND METHODOLOGY FOR DEVELOPMENT OF A HEALTH STATUS MEASURE [J].

BERGNER, M ;

BOBBITT, RA ;

KRESSEL, S ;

POLLARD, WE ;

GILSON, BS ;

MORRIS, JR .

INTERNATIONAL JOURNAL OF HEALTH SERVICES, 1976, 6 (03) :393-415

[8]

BLOOM BS, 1982, COST BENEFIT COST EF

[9]

Bush JW, 1973, HLTH STATUS INDEX CO

[10]

CHARLES EJ, 1978, HLTH EC RES ORG AM E

← 1 2 3 4 →